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Percutaneous Transhepatic 
Mitral Commissurotomy 
Kirti Punamiya, MD, Robert H. Beekman, MD, 
David Shim, MD, and 
David W.M. Muller, MD, FRACP, FASCI 
A novel, transhepatic approach to mitral valvuloplasty is de- 
scribed in a patient with an inferior vena caval filter. After trans- 
hepatic transseptal puncture, an lnoue dilatation catheter was 
passed through the hepatic parenchyma and across the atrial 
septum. Balloon mitral valvuloplasty was performed without 
complications. This approach should be considered when fem- 
oral venous access is restricted or is not feasible. 
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INTRODUCTION 
Percutaneous balloon mitral commissurotomy is a vi- 
able alternative to surgical commissurotomy or mitral 
valve replacement. Access to the mitral valve for balloon 
dilatation is conventionally achieved using a transseptal 
approach via the right femoral vein 111; a retrograde, 
transarterial approach also has been described [2]. We 
describe a novel approach used in a patient in whom a 
conventional transvenous approach was not possible be- 
cause of the presence of an inferior vena caval Greenfield 
filter. 
CASE REPORT 
A 40-yr-old man with steroid-dependent systemic lu- 
pus erythematosis and juvenile rheumatoid arthritis was 
referred for consideration of balloon mitral valvulo- 
plasty. Following a recent episode of bowel perforation 
and acute peritonitis, he had undergone colon resection 
and colostomy. His postoperative course was compli- 
cated by wound dehiscence, which was being allowed to 
heal by secondary intention, and by rapid atrial fibrilla- 
tion with congestive cardiac failure. Clinical examina- 
tion was consistent with underlying rheumatic mitral ste- 
nosis, and echocardiography showed a mean diastolic 
gradient of 17 mmHg across the mitral valve, pliable 
leaflets, no mitral regurgitation, and an estimated right 
ventricular systolic pressure of 67 mmHg. Mitral valve 
replacement surgery was considered inadvisable because 
of the presence of a persisting wound infection. Balloon 
mitral valvuloplasty via a femoral venous transseptal ap- 
proach was not feasible because of the presence of an 
inferior vena caval Greenfield filter inserted several 
months previously after an episode of acute pulmonary 
embolism. Transeptal catheterization was therefore per- 
formed using a percutaneous transhepatic approach. 
After informed consent was obtained, cannulation of a 
branch of the hepatic vein was performed under local 
anesthesia as previously described [3]. In brief, a 22- 
gauge Chiba needle (Cook, Bloomington, IN) was in- 
serted under fluoroscopic guidance between the ribs in 
the right midaxillary line horizontally midway into the 
substance of the liver. As the needle was withdrawn, a 
small amount of angiographic contrast was injected until 
a venous radicle was identified. The vessel was cannu- 
lated using a 0.018’’ guide wire (Cope wire, Cook) (Fig. 
1A) over which a 5F coaxial dilator was inserted. The 
small caliber wire was then replaced by a 0.035” J wire, 
which was advanced into the right atrium. Right heart 
catheterization was performed through an 8F sheath 
placed over the guidewire. The sheath and right heart 
catheter were then removed over a guidewire, and trans- 
septa1 puncture was performed without difficulty under 
fluoroscopic guidance. The gradient across the mitral 
valve was measured using the left atrial catheter and a 
left ventricular catheter advanced retrogradely from the 
left femoral artery. A mean gradient of 10.5 mmHg was 
recorded with a cardiac output of 5.OUmin by thermodi- 
lution giving an estimated mitral valve area of 1.33cm2. 
After measurement of baseline hemodynamics and the 
administration of 3,000 units intravenous heparin, a 
0.025” stainless steel Inoue guidewire was introduced 
through the transseptal catheter into the left atrium and a 
12Fr Inoue dilator was used to dilate the hepatic tract and 
atrial septum (Fig. 1B). A 28 mm Inoue balloon was then 
advanced unsheathed through the hepatic parenchyma 
and across the atrial septum. Difficulty was encountered 
in advancing the balloon across the mitral valve because 
of a relatively low atrial puncture site and a horizontal 
position of the catheter across the septum, which caused 
the curved catheter to be directed preferentially toward 
the right. The Inoue balloon was therefore removed, the 
transseptal catheter was replaced, and a 0.035” J wire 
was used to cross the mitral valve. This wire was ex- 
changed through an 8 French end-hole catheter for the 
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proach. A retrograde, nontransseptal approach, de- 
scribed by Stefanidis and colleagues [2], was considered 
feasible. However, the procedure requires a specially 
modified, steerable dilatation catheter that is not readily 
available in the United States. A third potential ap- 
proach, using transseptal catheterization through the 
caval filter and retrograde passage of a balloon dilatation 
catheter over a wire advanced from the femoral vein, was 
also considered. This technique, originally described by 
Babic [4], is limited by the need for large caliber sheaths 
in one or both femoral arteries to accommodate ade- 
quately sized balloon catheters. In our patient, femoral 
access on the right side was not possible because of 
contracture around a severely deformed and arthritic hip. 
Finally, a transjugular approach was considered but was 
rejected because of anatomic difficulties inherent in iden- 
tifying and engaging the foramen ovale and in crossing 
the septum from the superior approach with transseptal 
equipment designed for an inferior approach. 
We have previously reported a series of 18 children in 
whom diagnostic or therapeutic cardiac procedures were 
performed using a percutaneous transhepatic approach 
[3]. Sheath sizes up to 8Fr were used without vascular or 
hepatic injury for a variety of procedures including pul- 
monary valvuloplasty and closure of an atrial septal de- 
fect. Other investigators [5] have reported a small series 
of transhepatic procedures in which sheath sizes up to 
14Fr have been successfully used for dilatation of hepatic 
vein stenoses in children. In this patient, transhepatic 
access to the right heart was achieved rapidly and al- 
lowed completion of the assessment of baseline hemo- 
dynamics as quickly as could have been achieved using 
a femoral venous approach. Transeptal puncture and left 
atrial catheterization were accomplished without diffi- 
culty. Modification of the lnoue technique was required 
to allow appropriate orientation of the dilatation catheter 
and its passage into the left ventricle. Following com- 
pletion of the procedure, hemostasis was achieved using 
dacron-coated metal coils rather than the gelfoam 
pledgets used by other investigators [ 5 ] ,  because of the 
theoretical potential for gelfoam embolization into the 
pulmonary circulation, or into the systemic circulation 
across the residual atrial septal defect. Hemostasis was 
immediate after the introduction of the second Gianturco 
coil. 
Fig. 1. A. Fluoroscopic image showing the position of the 
0.018 guidewire, which was advanced through the Chiba nee- 
dle and substance of the liver, into the right sided cardiac cham- 
bers, and pulmonary circulation. B. lnoue dilator and guidewire 
passing through the liver, across the atrial septum, and into the 
left atrium. A pigtail catheter is also apparent in the left ventri- 
cle. C. lnoue balloon fully expanded across the mitral valve. D. 
Fluoroscopic image showing placement of the first of two Gi- 
anturco coils in the hepatic tract to secure hemostasis at the 
completion of the procedure. 
Inoue pigtail guidewire, which was coiled in the left 
ventricle. The Inoue balloon was then readily advanced 
to the left ventricle and inflated sequentially to a maxi- 
mum balloon size of 28 mm (Fig. 1C). After removal of 
the Inoue balloon, right heart catheterization was re- 
peated through a 12Fr sheath. The final mean mitral 
valve gradient was 5.4 mmHg with a cardiac output of 
5.5Llmin and estimated valve area of 2.33 cm2. The 
sheath was then pulled back from the hepatic venous 
radicle, a small volume of nonionic contrast was used to 
confirm the position of the sheath, and two Gianturco 
coils (0.038. x 4 cm X 3 mm and 0.038” X 5 cm X 5 
mm) were placed in the parenchymal tract between the 
hepatic vein and the capsule of the liver to secure hemo- 
stasis (Fig. 1D). The postprocedural course was uncom- 
plicated with no evidence of bleeding or hepatic injury 
by ultrasound or biochemical analysis of hepatic en- 
zymes. 
DISCUSSION 
This case illustrates an alternative approach for trans- 
venous mitral valvuloplasty in the setting of femoral 
venous or inferior vena caval occlusion. In this patient, 
access to the right heart from the femoral vein was re- 
stricted by the presence of a caval filter. Although the 
Inoue balloon has a relatively low profile before and after 
inflation, the risk of entrapment of the device in the filter 
was considered prohibitive to a femoral venous ap- 
CONCLUSIONS 
Transhepatic transseptal access is a feasible and tech- 
nically straightforward alternative for antegrade balloon 
mitral valvuloplasty in patients in whom femoral venous 
access is not possible or is limited by the presence of a 
caval filter. The excellent outcomes for transhepatic in- 
terventional procedures reported to date in small num- 
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bers of patients suggest that further evaluation of this 
approach is warranted not only in the pediatric popula- 
tion but also in appropriately selected adults. In these 
highly selected patients, use of the transhepatic approach 
should be limited to operators with extensive experience 
in transseptal catheterization, routine mitral balloon val- 
vuloplasty, and transhepatic venous cannulation. 
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